ap-2 gamma antibody Search Results


ap-2 gamma antibody  (Bio-Techne corporation)
90
Bio-Techne corporation ap-2 gamma antibody
Ap 2 Gamma Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ap-2+gamma+antibody/AP-2+gamma+Antibody/bio-techne+corporation___nb100-1516
Average 90 stars, based on 1 article reviews
ap-2 gamma antibody - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
ap2 gamma  (R&D Systems)
94
R&D Systems ap2 gamma
Ap2 Gamma, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ap-2+gamma+antibody/Human+AP-2+gamma+Antibody/pm37369645-792-49-50
Average 94 stars, based on 1 article reviews
ap2 gamma - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
tfap2c  (Proteintech)
93
Proteintech tfap2c
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Tfap2c, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ap-2+gamma+antibody/TFAP2C+Antibody/pmc08985761-70-18-20
Average 93 stars, based on 1 article reviews
tfap2c - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
goat polyclonal  (R&D Systems)
93
R&D Systems goat polyclonal
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Goat Polyclonal, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ap-2+gamma+antibody/Human+AP-2+gamma+Antibody/pmc10940163-327-141-146
Average 93 stars, based on 1 article reviews
goat polyclonal - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier
anti ap 2  (Novus Biologicals)
90
Novus Biologicals anti ap 2
<t>TFAP2C</t> transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.
Anti Ap 2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ap-2+gamma+antibody/AP-2+gamma+Antibody+(S03-8I2)/10__1523_slash_jneurosci__0089___15__2015-71-87-88
Average 90 stars, based on 1 article reviews
anti ap 2 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
bs 6694r  (Bioss)
91
Bioss bs 6694r
Antibodies used in this experiment.
Bs 6694r, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ap-2+gamma+antibody/AP2+gamma+Polyclonal+Antibody/pmc08488167-54-4-2
Average 91 stars, based on 1 article reviews
bs 6694r - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier
anti g2 cop antibody  (Proteintech)
85
Proteintech anti g2 cop antibody
Antibodies used in this experiment.
Anti G2 Cop Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 85/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ap-2+gamma+antibody/COPG2+Antibody/pm27005820-51-12-15
Average 85 stars, based on 1 article reviews
anti g2 cop antibody - by Bioz Stars, 2026-10
85/100 stars
  Buy from Supplier
ap 2 gamma antibody ap2g 6e4 4 biotin  (Novus Biologicals)
N/A
The AP 2 gamma Antibody AP2g 6E4 4 Biotin from Novus Biologicals is a mouse monoclonal antibody to AP 2 gamma This antibody reacts with human mouse The AP 2 gamma Antibody AP2g 6E4 4
   Buy from Supplier
ap 2 gamma antibody ap2g 6e4 4 dylight 550  (Novus Biologicals)
N/A
The AP 2 gamma Antibody AP2g 6E4 4 DyLight 550 from Novus Biologicals is a mouse monoclonal antibody to AP 2 gamma This antibody reacts with human mouse The AP 2 gamma Antibody AP2g 6E4
   Buy from Supplier
ap2 gamma tfap2c rabbit polyclonal antibody  (OriGene)
N/A
Rabbit Polyclonal Anti TFAP2C Antibody
   Buy from Supplier
anti-ap2 gamma antibody  (St Johns Laboratory)
N/A
Goat polyclonal to AP2 gamma. Conjugation note: Unconjugated Application note: ELISA, IHC Reactivity note: Human
   Buy from Supplier

Image Search Results


TFAP2C transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.

Journal: Frontiers in Oncology

Article Title: TFAP2C-Mediated lncRNA PCAT1 Inhibits Ferroptosis in Docetaxel-Resistant Prostate Cancer Through c-Myc/miR-25-3p/SLC7A11 Signaling

doi: 10.3389/fonc.2022.862015

Figure Lengend Snippet: TFAP2C transcriptionally activates PCAT1 expression in DTX-resistant cells. (A) Venn diagram showing the possible transcription factors within the promoter regions of PCAT1 by online bioinformatics analysis (HUMAN TFDB and ALGGEN). (B-D) The mRNA and protein levels of TFAP2C were detected by qRT-PCR and Western blot in DTX-resistant PCa cells and their sensitive cells. (E) The mRNA levels of TFAP2C, PCAT1 and SLC7A11 in PC3/DR cells were detected after transfected with siTFAP2C and control siRNA. (F) qRT-PCR assay was used to assess the expression of TFAP2C, PCAT1 and SLC7A11 in PC3 cells after TFAP2C overexpression. (G) Schematic diagram showing location of TFAP2C binding sites on the promoter regions of PCAT1. (H) ChIP-qPCR was used to detect the binding efficiency of TFAP2C on the PCAT1 promoter. (I) The luciferase activities were measured in TFAP2C overexpressed PC3 cells after co-transfected with PCAT1 wild-type and mutant reporter plasmids. (J) Cell viability was assessed by CCK-8 assay in TFAP2C-knockdown PC3 cells after transfected with PCAT1 and vector plasmids. (K) The relative expression of TFAP2C was measured by qRT-PCR in 30 pairs of clinical PCa samples. (L) The positive relation between TFAP2C and PCAT1 in clinical samples (n=30) by qRT-PCR. (M) The schematic diagram showing that TFAP2C-induced PCAT1 inhibits ferroptosis in DTX-resistant PCa cells through c-Myc/miR-25-3p/SLC7A11 signaling. The data are presented as the mean ± SD, * P < 0.05.

Article Snippet: The primary antibodies were as follows: SLC7A11 (1:1000, Abcam, USA, Cat. ab175186), GPX4 (1:1000, Abcam, USA, Cat. ab125066), TFAP2C (1:1000, Proteintech, China, Cat. 14572-1-AP), c-Myc (1:1000, Proteintech, Cat. 67447-1-Ig) and β-actin (1:1000, Proteintech, China, Cat. 66009-1-Ig).

Techniques: Expressing, Quantitative RT-PCR, Western Blot, Transfection, Control, Over Expression, Binding Assay, ChIP-qPCR, Luciferase, Mutagenesis, CCK-8 Assay, Knockdown, Plasmid Preparation

Antibodies used in this experiment.

Journal: Frontiers in Cell and Developmental Biology

Article Title: ESRRB Facilitates the Conversion of Trophoblast-Like Stem Cells From Induced Pluripotent Stem Cells by Directly Regulating CDX2

doi: 10.3389/fcell.2021.712224

Figure Lengend Snippet: Antibodies used in this experiment.

Article Snippet: CDX2 , Bioss , bs-6694R.

Techniques: